181 related articles for article (PubMed ID: 27353462)
1. Sexual dimorphism in the glucose homeostasis phenotype of the Aromatase Knockout (ArKO) mice.
Van Sinderen M; Steinberg G; Jorgensen SB; Honeyman J; Chow JDY; Simpson ER; Jones MEE; Boon WC
J Steroid Biochem Mol Biol; 2017 Jun; 170():39-48. PubMed ID: 27353462
[TBL] [Abstract][Full Text] [Related]
2. Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice.
Van Sinderen ML; Steinberg GR; Jørgensen SB; Honeyman J; Chow JD; Herridge KA; Winship AL; Dimitriadis E; Jones ME; Simpson ER; Boon WC
PLoS One; 2015; 10(8):e0136143. PubMed ID: 26317527
[TBL] [Abstract][Full Text] [Related]
3. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency.
Takeda K; Toda K; Saibara T; Nakagawa M; Saika K; Onishi T; Sugiura T; Shizuta Y
J Endocrinol; 2003 Feb; 176(2):237-46. PubMed ID: 12553872
[TBL] [Abstract][Full Text] [Related]
4. Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse.
Van Sinderen ML; Steinberg GR; Jørgensen SB; To SQ; Knower KC; Clyne CD; Honeyman J; Chow JD; Herridge KA; Jones ME; Simpson ER; Boon WC
PLoS One; 2014; 9(2):e87230. PubMed ID: 24520329
[TBL] [Abstract][Full Text] [Related]
5. Aromatase deficiency in hematopoietic cells improves glucose tolerance in male mice through skeletal muscle-specific effects.
Rubinow KB; den Hartigh LJ; Goodspeed L; Wang S; Oz OK
PLoS One; 2020; 15(1):e0227830. PubMed ID: 31971970
[TBL] [Abstract][Full Text] [Related]
6. The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis.
Hewitt KN; Boon WC; Murata Y; Jones ME; Simpson ER
Endocrinology; 2003 Sep; 144(9):3895-903. PubMed ID: 12933663
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and adiposity--utilizing models of aromatase deficiency to explore the relationship.
Jones ME; McInnes KJ; Boon WC; Simpson ER
J Steroid Biochem Mol Biol; 2007; 106(1-5):3-7. PubMed ID: 17643292
[TBL] [Abstract][Full Text] [Related]
8. A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse.
Chow JD; Jones ME; Prelle K; Simpson ER; Boon WC
J Endocrinol; 2011 Sep; 210(3):323-34. PubMed ID: 21705395
[TBL] [Abstract][Full Text] [Related]
9. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity.
Jones ME; Thorburn AW; Britt KL; Hewitt KN; Wreford NG; Proietto J; Oz OK; Leury BJ; Robertson KM; Yao S; Simpson ER
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12735-40. PubMed ID: 11070087
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of estrogen receptors in the forebrain of aromatase knockout (ArKO) mice.
Agarwal VR; Sinton CM; Liang C; Fisher C; German DC; Simpson ER
Mol Cell Endocrinol; 2000 Apr; 162(1-2):9-16. PubMed ID: 10854693
[TBL] [Abstract][Full Text] [Related]
11. Impaired spatial reference memory in aromatase-deficient (ArKO) mice.
Martin S; Jones M; Simpson E; van den Buuse M
Neuroreport; 2003 Oct; 14(15):1979-82. PubMed ID: 14561933
[TBL] [Abstract][Full Text] [Related]
12. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse.
Hewitt KN; Pratis K; Jones ME; Simpson ER
Endocrinology; 2004 Apr; 145(4):1842-8. PubMed ID: 14684602
[TBL] [Abstract][Full Text] [Related]
13. Effect of estrogen deficiency in the male: the ArKO mouse model.
Murata Y; Robertson KM; Jones ME; Simpson ER
Mol Cell Endocrinol; 2002 Jul; 193(1-2):7-12. PubMed ID: 12160996
[TBL] [Abstract][Full Text] [Related]
14. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue.
Jones ME; Thorburn AW; Britt KL; Hewitt KN; Misso ML; Wreford NG; Proietto J; Oz OK; Leury BJ; Robertson KM; Yao S; Simpson ER
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):3-9. PubMed ID: 11850201
[TBL] [Abstract][Full Text] [Related]
15. Bone has a sexually dimorphic response to aromatase deficiency.
Oz OK; Zerwekh JE; Fisher C; Graves K; Nanu L; Millsaps R; Simpson ER
J Bone Miner Res; 2000 Mar; 15(3):507-14. PubMed ID: 10750565
[TBL] [Abstract][Full Text] [Related]
16. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse.
Ling S; Dai A; Dilley RJ; Jones M; Simpson E; Komesaroff PA; Sudhir K
Circulation; 2004 Feb; 109(4):537-43. PubMed ID: 14732746
[TBL] [Abstract][Full Text] [Related]
17. Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life.
Bianco JJ; McPherson SJ; Wang H; Prins GS; Risbridger GP
Am J Pathol; 2006 Jun; 168(6):1869-78. PubMed ID: 16723702
[TBL] [Abstract][Full Text] [Related]
18. The lack of estrogen and excess luteinizing hormone are responsible for the female ArKO mouse phenotype.
Liew SH; Drummond AE; Jones ME; Findlay JK
Mol Cell Endocrinol; 2010 Oct; 327(1-2):56-64. PubMed ID: 20546829
[TBL] [Abstract][Full Text] [Related]
19. Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity.
Head GA; Obeyesekere VR; Jones ME; Simpson ER; Krozowski ZS
Endocrinology; 2004 Sep; 145(9):4286-91. PubMed ID: 15178650
[TBL] [Abstract][Full Text] [Related]
20. Enhanced urinary odor discrimination in female aromatase knockout (ArKO) mice.
Wesson DW; Keller M; Douhard Q; Baum MJ; Bakker J
Horm Behav; 2006 May; 49(5):580-6. PubMed ID: 16448653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
